4ZYP

Crystal Structure of Motavizumab and Quaternary-Specific RSV-Neutralizing Human Antibody AM14 in Complex with Prefusion RSV F Glycoprotein

Experimental procedure

Experimental method	SINGLE WAVELENGTH
Source type	SYNCHROTRON
Source details	APS BEAMLINE 19-ID
Synchrotron site	APS
Beamline	19-ID
Temperature [K]	100
Detector technology	CCD
Collection date	2014-07-20
Detector	ADSC QUANTUM 315r
Wavelength(s)	0.9792
Spacegroup name	P 1 21 1
Unit cell lengths	114.380, 210.290, 118.200
Unit cell angles	90.00, 100.46, 90.00

Refinement procedure

Resolution	49.386 - 5.500
R-factor	0.2137
Rwork	0.210
R-free	0.27680
Structure solution method	MOLECULAR REPLACEMENT
Starting model (for MR)	4jhw 3ixt 4zyk
RMSD bond length	0.006
RMSD bond angle	1.348
Data reduction software	MOSFLM
Data scaling software	Aimless (0.3.11)
Phasing software	PHASER
Refinement software	PHENIX (1.9_1692)

Data quality characteristics

	Overall	Inner shell	Outer shell
Low resolution limit [Å]	49.590	49.590	6.150
High resolution limit [Å]	5.500	12.300	5.500
Rmerge	0.182	0.067	0.789
Rpim	0.125	0.049	0.544
Total number of observations	51879	4670	14295
Number of reflections	17434
<I/σ(I)>	4.8	13	1.5
Completeness [%]	97.5	95.4	97.6
Redundancy	3	3	2.9
CC(1/2)	0.939	0.916	0.553

Crystallization Conditions

crystal ID	method	pH	temperature	details
1	VAPOR DIFFUSION, HANGING DROP	6.5	293	5.645mg/mL EndoH digested DS-Cav1 + AM14 Fab + Motavizumab Fab, 11.4% PEG8000, 1.71% MPD, 0.1M Imidazole pH 6.5